How a Small Country Thinks Big: Leadership Lessons from Switzerland
If you lead anything small in a world of giants—a mid‑cap, a division, a startup, even a small country—three questions should keep you awake at night:
· If you are a small player, how are you going to compete and win against the giants?
· If your future landscape is different to the past how are you going to compete differently?
· If your external risks and uncertainties are growing, can you diversify away some of the risk?
A look at the national strategy of Switzerland, a minnow in a world of aggressive whales, gives some insights. The themes are the same, the complexities are far greater than for a business.
Switzerland forty years ago
Spending eight to ten weeks a year in Switzerland makes me reflect on where Switzerland has come from in the last forty years and what will happen in its next phase of development.
When I arrived in Lausanne Switzerland in 1984 for my MBA program at IMD, Switzerland was an idyllic calm country known for its mountain air, neutrality, chocolate, watches, precision machines, discreet private banking and a stable currency.
The world changed, and so did Switzerland
The world was a different place to today. The US had Ronald Reagan and projected strength and confidence with military and economic power, and believed in globalisation. The Soviet Union was still around, but there were cracks emerging and they were not in the same economic league as the US. China under Deng was changing after the cultural revolution of Mao. The UK had Margaret Thatcher shaking things up and breaking the unions. We were in the early days of computing. The global population was under five billion and over 40% of the people were in extreme poverty.
Forty years later, the world is now unrecognisable to 1984. It is infinitely more complex. The US under Trump is playing tariff poker and power games with everyone as it desperately tries to pretend they are still in a unipolar world. Russia is playing military chess as it tries to restore a semblance of the Soviet Union starting with Ukraine. China is playing Go and has surpassed the US economically on a purchasing power parity basis. It is stepping into holes the US has deserted with both hard and soft power influence and is creating global influence particularly in the Global South. India under Modi is an emerging global economic powerhouse. The EU, although technically powerful, is disorganised and operates primarily as individual countries watching from the sidelines. We have a real climate and environmental crisis. We have a technology race in AI and robotics. The global population is over eight billion, with many countries ageing and starting to decline in numbers, and under 10% of the people are in extreme poverty.
So how has Switzerland, this little county, fared over this period? At the most simplistic level the Swiss Franc has gone from strength to strength vs. all major currencies. Forty years ago, one US dollar bought about 2.5 Swiss Francs and today you get 0.80 Swiss Francs.
In my own analysis in 2022, I picked the Top 25 Nations in GDP/Capita (populations over 4 million), and then built a scorecard across nine societal dimensions. Taking a simple average of the rankings, Switzerland was #1 and the US was #23. See the table below:

According to IMD’s World Competitiveness Reports in 2025, Switzerland is a leader across a number of dimensions - #1 overall, #1 in government efficiency, #1 in infrastructure, and also #1 in digital competitiveness. It is also highly ranked in talent competitiveness. In addition, the World Intellectual Property Organisation (WIPO) Global Innovation Index ranked Switzerland as the world’s most innovative country. It is ranked weaker in industrial economic performance but still punches well above its weight.
On the ground, the skeleton of discreet but globally dominant private banking, diversified high‑end manufacturing (watches, machinery, instruments), and strict neutrality backed by a strong Swiss Franc is still in place. But what now sits on top is the pharmaceutical and biotech sector that has been the driving force behind its development. Pharma and chemicals now account for roughly half of all Swiss goods exports and a very large share of recent GDP growth.
Switzerland’s companies have played the strong Franc and high‑wage game better than almost anyone:
· Life sciences: Roche, Novartis and a thick layer of biotech and medtech firms turned the Basel–Zürich–Leman triangle into one of the world’s densest health‑innovation corridors. The sectors value added has tripled in the last decade and now drives more than 40% of the country’s economic expansion.
· Precision manufacturing: Smaller but still world‑class players in machinery, robotics and instruments survived currency shocks by moving relentlessly up‑market.
· Financial services: Despite scandals and consolidation, Switzerland remains the leading global hub for cross‑border private wealth, with record assets under management and a reputation for stability that is hard to replicate.
As a small country competing in a land of giants, Switzerland moved into higher and higher value added areas of business. Critically, supporting their progress has been a strong culture with predictable regulation, talent development, world class infrastructure, and leadership in government efficiency.
Foreign policy has also evolved. The Foreign Policy Strategy 2024–27 marks a shift from “neutral by standing aside” to “neutral but actively engaged,” centred on four pillars: peace and security, prosperity and competitiveness, environment, and democracy/human rights. Easy to say but harder to operationalise.
The shift since the 1980s is stark: Switzerland has moved from being primarily an affluent, safe, neutral country to being the world’s premier high‑end production node in three domains - pharma/biotech, precision manufacturing, and wealth management - underpinned by some of the most efficient public institutions and infrastructure on earth.
The world is changing again and so must Switzerland
The model that worked in the last forty years now has vulnerabilities on several fronts:
Big country economic power plays
The major countries are starting to exercise their economic power. The US has weaponised trade and is pressurizing for on-shoring. China continues its march to dominate sectors of the future including those related to clean energy, industrial machinery and robotics, and chemical processing and generic drugs.
More protectionism, less globalisation
There is a growing trend towards protectionism versus openness. This often is most intensely reflected in government contracts. We should not forget that governments spend typically comprises about 30% to 40% of GDP.
Dominant strengths can also be vulnerabilities
Switzerland’s critical point of success over the last 40 years, the pharma and biotech sector, is now also its biggest potential point of weakness. There is huge pharmaceutical on-shoring pressure coming from the Trump administration, knowing that the US is also Switzerland’s biggest export market. Overall pressure on pharmaceutical pricing is also growing as countries come to grips with the rising health costs of an ageing society.
New demographics
Demographic pressure is building: ageing, pensions and health‑care costs now feature prominently in OECD and national diagnostics of Swiss vulnerabilities.
AI changing the future
The AI race is on with intense capital investment on all fronts and severe levels of competition.
How can Switzerland adapt?
With the new geopolitical landscape, demographic changes and the likely shocks from the role of AI going forward, how should Switzerland evolve strategically to maintain its position in the world. Integrating a range of views provides the following four strategic perspectives:
1. Double down on strengths to build as big a strategic moat as possible.
a. Continue to foster a strong, cohesive, buy-Swiss and progressive national culture with its updated ‘neutrality’ agenda.
b. Continue to drive government efficiency with a proactive view to adopting AI where it can make a difference.
c. Continue to build and maintain a best-in-class core and digital infrastructure for the future.
d. Maintain the ‘safe-haven’ leadership position for private wealth. This includes currency management, taxation, and predictable and favourable regulatory management.
e. Continue to progress the ‘talent management’ agenda to develop, attract and retain top talent, and be a leader in reskilling the workforce.
f. Assist in solving ‘capital gaps’ for high-value emerging and growth businesses
2. Move to even higher value added products and services and diversify focus into more niche markets.
a. Pharma and biochem to build the leading applied tech/AI stacks for data, faster innovation, and integration into new products and services. In addition, to build adjacent high value leadership positions – such as in medtech, diagnostics and prevention.
b. Precision machinery companies to be leaders in robotics and capable of moving to higher value market segments.
c. Expand portfolio of leading high value niche businesses with a strong export focus. This could be in areas such as automation, or the engineering of new climate/energy solutions.
3. Diversify export focus away from US and China
a. Focus on exploiting the opportunities in the India‑EFTA TEPA, EFTA-MERCOSUR and ASEAN agreements. Look at other potential agreements and bilateral treaties that would help Swiss companies achieve better market access.
b. Use the Africa Strategy 2025–28 to build early‑stage positions in fast‑growing African markets rather than arriving late.
4. Get ahead of the ageing demographic assisted by the development and adoption of AI and robotics
a. Workforce optimisation in an ageing demographic through talent attraction, optimise working age employment, selectively increasing levels of working age involvement in the employment sector, build workforce reskilling into the national culture.
b. Aggressive development of the AI automation and robotics sector.
c. Build the most cost-effective model for a healthy ageing population. This will come from an integrated approach to mixing social services and healthcare, shifting to a prevention focus in health care, and selective use of automation and robotics for elderly services.
The Leadership Takeaway
Switzerland’s story isn’t just interesting; it’s useful. A small player can outperform. Know your market. Think differently. Build lasting strengths. Move ahead of market changes.
As a leader of a small or medium size company, here are some themes to think about:
· A different future requires a different strategy.
· Play to strengths and play a different game to the giants.
· Success sits on the shoulder of culture, the quality of people, and your engine room of capabilities.
· Double down on strengths as they are almost always relevant for the future. Build deeper value-add to create deeper strategic moats.
· In an age of uncertainty, diversification is critical for risk reduction.
· Know your markets and customers, and move ahead of your competitors as you see change happening.